Indocyanine green angiography in oncoplastic breast surgery, a prospective study

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Indocyanine green angiography in oncoplastic breast surgery, a prospective study. / Lauritzen, Elisabeth; Bredgaard, Rikke; Laustsen-Kiel, Cecilie Mullerup; Hansen, Laura; Tvedskov, Tove; Damsgaard, Tine Engberg.

I: Journal of Plastic, Reconstructive and Aesthetic Surgery, Bind 85, 2023, s. 276-286.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Lauritzen, E, Bredgaard, R, Laustsen-Kiel, CM, Hansen, L, Tvedskov, T & Damsgaard, TE 2023, 'Indocyanine green angiography in oncoplastic breast surgery, a prospective study', Journal of Plastic, Reconstructive and Aesthetic Surgery, bind 85, s. 276-286. https://doi.org/10.1016/j.bjps.2023.07.022

APA

Lauritzen, E., Bredgaard, R., Laustsen-Kiel, C. M., Hansen, L., Tvedskov, T., & Damsgaard, T. E. (2023). Indocyanine green angiography in oncoplastic breast surgery, a prospective study. Journal of Plastic, Reconstructive and Aesthetic Surgery, 85, 276-286. https://doi.org/10.1016/j.bjps.2023.07.022

Vancouver

Lauritzen E, Bredgaard R, Laustsen-Kiel CM, Hansen L, Tvedskov T, Damsgaard TE. Indocyanine green angiography in oncoplastic breast surgery, a prospective study. Journal of Plastic, Reconstructive and Aesthetic Surgery. 2023;85:276-286. https://doi.org/10.1016/j.bjps.2023.07.022

Author

Lauritzen, Elisabeth ; Bredgaard, Rikke ; Laustsen-Kiel, Cecilie Mullerup ; Hansen, Laura ; Tvedskov, Tove ; Damsgaard, Tine Engberg. / Indocyanine green angiography in oncoplastic breast surgery, a prospective study. I: Journal of Plastic, Reconstructive and Aesthetic Surgery. 2023 ; Bind 85. s. 276-286.

Bibtex

@article{78c104f04cc944a0a07c35960abec390,
title = "Indocyanine green angiography in oncoplastic breast surgery, a prospective study",
abstract = "Introduction: The use of Indocyanine green angiography (ICG-A) in oncoplastic breast-conserving surgery (OBCS) has not yet been investigated. This prospective trial applied ICG-A in volume displacement and replacement OBCS to localize perforators and determine tissue supplied by the perforator. Furthermore, to investigate and correlate the intraoperative ICG-A to postoperative surgical site infection, skin necrosis, epidermolysis, and timely onset of adjuvant therapy. Methods: ICG-A was performed at three pre-set timepoints during surgery; after lumpectomy, upon dissection of possible perforators, and after wound closure. All patients were followed with clinical evaluations before surgery, 4 weeks, 4–6 months, and 12 months postoperatively. Results: Eleven patients were included: seven volume displacement and four volume replacement OBCS. ICG-A located the tissue supplied by the perforator and demonstrated sufficient perfusion in all cases. The ICG-A corresponded to the surgeons{\textquoteright} clinical assessment. One patient developed a postoperative infection and seroma and was treated conservatively. No patients had postoperative necrosis, loss of reconstruction, or lymphedema of the arm. Edema of the breast occurred in four patients (36.4%). Scar assessments were significantly worse at 4-weeks and 4–6 months. The quality of life improved significantly during follow-up. Adjuvant treatment was administered timely in all cases. Conclusion: ICG-A was feasible for OBCS in assessing intraoperative perfusion. Perfusion was sufficient in all patients and corresponded to the surgeon's clinical evaluation. No patients developed postoperative necrosis. Though edema of the breast occurred in 36.4%, a larger sample size is needed to investigate a possible correlation with ICG-A. Further studies, which includes patients requiring extensive tissue replacement challenging the borders of perfusion, are needed.",
keywords = "ICG-A, Indocyanine green angiography, Oncoplastic breast surgery, Volume displacement, Volume replacement",
author = "Elisabeth Lauritzen and Rikke Bredgaard and Laustsen-Kiel, {Cecilie Mullerup} and Laura Hansen and Tove Tvedskov and Damsgaard, {Tine Engberg}",
note = "Publisher Copyright: {\textcopyright} 2023 British Association of Plastic, Reconstructive and Aesthetic Surgeons",
year = "2023",
doi = "10.1016/j.bjps.2023.07.022",
language = "English",
volume = "85",
pages = "276--286",
journal = "Journal of plastic, reconstructive & aesthetic surgery : JPRAS",
issn = "1748-6815",
publisher = "Elsevier",

}

RIS

TY - JOUR

T1 - Indocyanine green angiography in oncoplastic breast surgery, a prospective study

AU - Lauritzen, Elisabeth

AU - Bredgaard, Rikke

AU - Laustsen-Kiel, Cecilie Mullerup

AU - Hansen, Laura

AU - Tvedskov, Tove

AU - Damsgaard, Tine Engberg

N1 - Publisher Copyright: © 2023 British Association of Plastic, Reconstructive and Aesthetic Surgeons

PY - 2023

Y1 - 2023

N2 - Introduction: The use of Indocyanine green angiography (ICG-A) in oncoplastic breast-conserving surgery (OBCS) has not yet been investigated. This prospective trial applied ICG-A in volume displacement and replacement OBCS to localize perforators and determine tissue supplied by the perforator. Furthermore, to investigate and correlate the intraoperative ICG-A to postoperative surgical site infection, skin necrosis, epidermolysis, and timely onset of adjuvant therapy. Methods: ICG-A was performed at three pre-set timepoints during surgery; after lumpectomy, upon dissection of possible perforators, and after wound closure. All patients were followed with clinical evaluations before surgery, 4 weeks, 4–6 months, and 12 months postoperatively. Results: Eleven patients were included: seven volume displacement and four volume replacement OBCS. ICG-A located the tissue supplied by the perforator and demonstrated sufficient perfusion in all cases. The ICG-A corresponded to the surgeons’ clinical assessment. One patient developed a postoperative infection and seroma and was treated conservatively. No patients had postoperative necrosis, loss of reconstruction, or lymphedema of the arm. Edema of the breast occurred in four patients (36.4%). Scar assessments were significantly worse at 4-weeks and 4–6 months. The quality of life improved significantly during follow-up. Adjuvant treatment was administered timely in all cases. Conclusion: ICG-A was feasible for OBCS in assessing intraoperative perfusion. Perfusion was sufficient in all patients and corresponded to the surgeon's clinical evaluation. No patients developed postoperative necrosis. Though edema of the breast occurred in 36.4%, a larger sample size is needed to investigate a possible correlation with ICG-A. Further studies, which includes patients requiring extensive tissue replacement challenging the borders of perfusion, are needed.

AB - Introduction: The use of Indocyanine green angiography (ICG-A) in oncoplastic breast-conserving surgery (OBCS) has not yet been investigated. This prospective trial applied ICG-A in volume displacement and replacement OBCS to localize perforators and determine tissue supplied by the perforator. Furthermore, to investigate and correlate the intraoperative ICG-A to postoperative surgical site infection, skin necrosis, epidermolysis, and timely onset of adjuvant therapy. Methods: ICG-A was performed at three pre-set timepoints during surgery; after lumpectomy, upon dissection of possible perforators, and after wound closure. All patients were followed with clinical evaluations before surgery, 4 weeks, 4–6 months, and 12 months postoperatively. Results: Eleven patients were included: seven volume displacement and four volume replacement OBCS. ICG-A located the tissue supplied by the perforator and demonstrated sufficient perfusion in all cases. The ICG-A corresponded to the surgeons’ clinical assessment. One patient developed a postoperative infection and seroma and was treated conservatively. No patients had postoperative necrosis, loss of reconstruction, or lymphedema of the arm. Edema of the breast occurred in four patients (36.4%). Scar assessments were significantly worse at 4-weeks and 4–6 months. The quality of life improved significantly during follow-up. Adjuvant treatment was administered timely in all cases. Conclusion: ICG-A was feasible for OBCS in assessing intraoperative perfusion. Perfusion was sufficient in all patients and corresponded to the surgeon's clinical evaluation. No patients developed postoperative necrosis. Though edema of the breast occurred in 36.4%, a larger sample size is needed to investigate a possible correlation with ICG-A. Further studies, which includes patients requiring extensive tissue replacement challenging the borders of perfusion, are needed.

KW - ICG-A

KW - Indocyanine green angiography

KW - Oncoplastic breast surgery

KW - Volume displacement

KW - Volume replacement

U2 - 10.1016/j.bjps.2023.07.022

DO - 10.1016/j.bjps.2023.07.022

M3 - Journal article

C2 - 37541044

AN - SCOPUS:85166525007

VL - 85

SP - 276

EP - 286

JO - Journal of plastic, reconstructive & aesthetic surgery : JPRAS

JF - Journal of plastic, reconstructive & aesthetic surgery : JPRAS

SN - 1748-6815

ER -

ID: 371922921